Shareable Research Card

ViewRay, Inc. Return On Equity

This metric view shows ViewRay, Inc. return on equity history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context
Latest reported period: 2022
Latest reported value
-94%

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Return Loop

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update
Latest period end 31 Dec 2022
Why come back
Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
  • Current latest reported period: 2022.
  • Latest reported value on this page: -94%.
  • Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Latest update

Latest update for Return On Equity

New fact period available

Latest reported return on equity: -94%. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

31 Dec 2022

Page type

Metric history

Latest period

2022

SEC-backed company facts were refreshed from filings filed on 11 May 2023.

Benchmark Context

How Return On Equity compares with peers

ViewRay, Inc. is outside the visible top 120 companies for return on equity in the current sample.

Compared with

Compared with 120 companies reporting return on equity in %. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about -0.1x the current sample midpoint. Return On Equity is down about 26% versus the comparable prior period.

  • Visible rows currently span reported period ends from 30 Jun 2015 to 28 Feb 2026.
  • Nearby companies in this sample: Wellgistics Health, Inc. and XCF Global, Inc..
  • Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Save this filer page

Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.

Financial Metric Page

ViewRay, Inc.: Return On Equity

Latest period: 2022. Period end: 31 Dec 2022. Units: %. Frequency: annual and quarterly.

Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

What This Metric Tells You

  • Shows the reported level of return on equity over 31 Mar 2015 - 31 Dec 2022.
  • Includes year-over-year change points to highlight acceleration or slowdown.
  • Built from 8 SEC fact rows for this metric and issuer.

How To Read This Chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use annual sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.

Compare This Metric Across Companies

Compare latest available Return On Equity levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

Rank Company Latest value Reported period Next step
1 Wellgistics Health, Inc. (wgrx) 141760% Quarter - 31 Dec 2025 Open Wellgistics Health, Inc. Return On Equity
2 XCF Global, Inc. (safx) 77635% Quarter - 31 Dec 2025 Open XCF Global, Inc. Return On Equity
3 Cardiff Lexington Corp (cdix) 49573% Year - 31 Dec 2025 Open Cardiff Lexington Corp Return On Equity
4 Bionik Laboratories Corp. (bnkl) 46191% Quarter - 31 Mar 2023 Open Bionik Laboratories Corp. Return On Equity
5 Savara Inc (svra) 43610% Year - 31 Dec 2025 Open Savara Inc Return On Equity
6 Athenex, Inc. 25553% Quarter - 31 Dec 2022 Open Athenex, Inc. Return On Equity

Metric Details

Metric
Return On Equity (ROE)
Taxonomy
ratio
Units tracked
%
Frequency coverage
annual and quarterly
History range
31 Mar 2015 - 31 Dec 2022
Facts on this page
8
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Metric-level SEC endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)
Return On Equity, Quarterly (%)

ViewRay, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2022 -94% -19% -26% 01 Jan 2022 31 Dec 2022
2021 -74% -8% -12% 01 Jan 2021 31 Dec 2021
2020 -66% +15% +19% 01 Jan 2020 31 Dec 2020
2019 -82% -12% -18% 01 Jan 2019 31 Dec 2019
2018 -69% -490% -116% 01 Jan 2018 31 Dec 2018
2017 421% +263% +166% 01 Jan 2017 31 Dec 2017
2016 158% 01 Jan 2016 31 Dec 2016

ViewRay, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2015 -4104016% 01 Jan 2015 31 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.